Probiotics ameliorate atopic dermatitis by modulating the dysbiosis of the gut microbiota in dogsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether gut bacterial imbalance is linked to canine atopic dermatitis and whether probiotics help through the gut-skin axis. Atopic dermatitis is a chronic itchy inflammatory skin disease in dogs. Researchers compared gut microbiota of healthy and affected dogs at baseline using 16S rRNA sequencing. They then gave all dogs a probiotic for 16 weeks and tracked skin severity scores and microbiome changes.
Who was studied?
The study enrolled 34 privately owned dogs: 11 clinically healthy and 23 with atopic dermatitis. Age, body weight, and sex did not differ significantly between groups. Dogs recently on antibiotics, under nine months old, or on weaning diets were excluded. Fecal samples were collected at baseline, 8 weeks, and 16 weeks. All dogs received a daily probiotic of three bacterial strains at 5 x 10^9 colony-forming units per gram.
What were the most important findings?
Affected dogs had significantly lower gut diversity than healthy dogs at baseline. Fusobacterium, Megamonas, Collinsella, and other genera were enriched in healthy dogs, while Clostridioides, Erysipelatoclostridium, and Clostridium were enriched in affected dogs. Disease severity by CADESI-4 correlated negatively with diversity and with Fusobacterium and Megamonas abundance. Over 16 weeks the mean CADESI-4 score fell from 24.57 to 19.04, and the itch score fell from 2.78 to 1.80. Seven of 23 dogs improved by more than 50 percent.
What are the greatest implications of this study?
The results support probiotics as an add-on therapy for canine atopic dermatitis that works by restoring gut microbial diversity. Dogs with a good outcome gained diversity, while non-responders did not. This points to microbiome-targeted management as a complement to immune-suppressing drugs that carry side effects. The study lacked an untreated control group, so placebo and natural variation cannot be ruled out. Functions were predicted from 16S data, not directly measured.